share_log

Altimmune | DEF 14A: Definitive information statements

Altimmune | DEF 14A: Definitive information statements

Altimmune | DEF 14A:股東委託書決議
美股SEC公告 ·  08/15 16:13

Moomoo AI 已提取核心訊息

Altimmune, Inc., a biopharmaceutical company, has announced its 2024 Annual Meeting of Stockholders to be held virtually on September 26, 2024. The meeting will include the election of eight directors, the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and an advisory vote on executive compensation. Stockholders are invited to attend the meeting online, vote electronically, and submit questions. The Board of Directors urges stockholders to read the attached Proxy Statement carefully and vote on the proposals outlined. The company's CEO, Vipin K. Garg, Ph.D., expressed gratitude for continued support and emphasized the importance of stockholder votes.
Altimmune, Inc., a biopharmaceutical company, has announced its 2024 Annual Meeting of Stockholders to be held virtually on September 26, 2024. The meeting will include the election of eight directors, the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and an advisory vote on executive compensation. Stockholders are invited to attend the meeting online, vote electronically, and submit questions. The Board of Directors urges stockholders to read the attached Proxy Statement carefully and vote on the proposals outlined. The company's CEO, Vipin K. Garg, Ph.D., expressed gratitude for continued support and emphasized the importance of stockholder votes.
生物製藥公司Altimmune, Inc.宣佈於2024年9月26日以虛擬方式召開2024年股東年會。會議將包括選舉8名董事,覈准安永會計師事務所爲截至2024年12月31日的獨立註冊公共會計師事務所,以及對執行薪酬進行諮詢性投票。股東們被邀請在線參加會議,以電子方式投票並提交問題。董事會敦促股東們仔細閱讀附上的代理聲明,並對提出的建議投票。公司首席執行官Vipin k. Garg博士對持續的支持表示感激,並強調股東投票的重要性。
生物製藥公司Altimmune, Inc.宣佈於2024年9月26日以虛擬方式召開2024年股東年會。會議將包括選舉8名董事,覈准安永會計師事務所爲截至2024年12月31日的獨立註冊公共會計師事務所,以及對執行薪酬進行諮詢性投票。股東們被邀請在線參加會議,以電子方式投票並提交問題。董事會敦促股東們仔細閱讀附上的代理聲明,並對提出的建議投票。公司首席執行官Vipin k. Garg博士對持續的支持表示感激,並強調股東投票的重要性。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息